Federal Register / Vol. 87, No. 62 / Thursday, March 31, 2022 / Notices 18771 

1 17 CFR 145.9. 

2 17 CFR 23.600, 23.601, 23.602, 23.603, 23.606, 

and 23.607. 

3 7 U.S.C. 6s(j). 

4For the definition of SD, see section 1a(49) of 

the CEA and Commission regulation 1.3. 7 U.S.C. 

1a(49) and 17 CFR 1.3. 

5For the definitions of MSP, see section 1a(33) of 

the CEA and Commission regulation 1.3. 7 U.S.C. 

1a(33) and 17 CFR 1.3. 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

All comments submitted in response 

to this notice are a matter of public 

record. USPTO will include or 

summarize each comment in the request 

to OMB to approve this information 

collection. Before including an address, 

phone number, email address, or other 

personal identifying information (PII) in 

a comment, be aware that the entire 

comment—including PII—may be made 

publicly available at any time. While 

you may ask in your comment to 

withhold PII from public view, USPTO 

cannot guarantee that it will be able to 

do so. 

Kimberly Hardy, 

Information Collections Officer, Office of the 

Chief Administrative Officer, United States 

Patent and Trademark Office. 

[FR Doc. 2022–06765 Filed 3–30–22; 8:45 am] 

BILLING CODE 3510–16–P 

COMMODITY FUTURES TRADING 

COMMISSION 

Agency Information Collection 

Activities: Notice of Intent To Extend 

Collection 3038–0084: Regulations 

Establishing and Governing the Duties 

of Swap Dealers and Major Swap 

Participants 

AGENCY: Commodity Futures Trading 

Commission. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995 

(‘‘PRA’’), this notice announces that the 

Information Collection Request (‘‘ICR’’) 

abstracted below has been forwarded to 

the Office of Information and Regulatory 

Affairs (‘‘OIRA’’), of the Office of 

Management and Budget (‘‘OMB’’), for 

review and comment. The ICR describes 

the nature of the information collection 

and its expected costs and burden. 

DATES: Comments must be submitted on 

or before May 2, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be 

submitted within 30 days of this 

notice’s publication to OIRA, at https:// 

www.reginfo.gov/public/do/PRAMain. 

Please find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the website’s 

search function. Comments can be 

entered electronically by clicking on the 

‘‘comment’’ button next to the 

information collection on the ‘‘OIRA 

Information Collections Under Review’’ 

page, or the ‘‘View ICR—Agency 

Submission’’ page. A copy of the 

supporting statement for the collection 

of information discussed herein may be 

obtained by visiting https://

www.reginfo.gov/public/do/PRAMain. 

In addition to the submission of 

comments to https://Reginfo.gov as 

indicated above, a copy of all comments 

submitted to OIRA may also be 

submitted to the Commodity Futures 

Trading Commission (the 

‘‘Commission’’ or ‘‘CFTC’’) by clicking 

on the ‘‘Submit Comment’’ box next to 

the descriptive entry for OMB Control 

No. 3038–0084, at https://

comments.cftc.gov/FederalRegister/ 

PublicInfo.aspx. 

Or by either of the following methods: 

• Mail: Christopher Kirkpatrick, 

Secretary of the Commission, 

Commodity Futures Trading 

Commission, Three Lafayette Centre, 

1155 21st Street NW, Washington, DC 

20581. 

• Hand Delivery/Courier: Same as 

Mail above. 

All comments must be submitted in 

English, or if not, accompanied by an 

English translation. Comments 

submitted to the Commission should 

include only information that you wish 

to make available publicly. If you wish 

the Commission to consider information 

that you believe is exempt from 

disclosure under the Freedom of 

Information Act, a petition for 

confidential treatment of the exempt 

information may be submitted according 

to the procedures established in § 145.9 

of the Commission’s regulations.1 The 

Commission reserves the right, but shall 

have no obligation, to review, prescreen, filter, redact, refuse or remove 

any or all of your submission from 

https://www.cftc.gov that it may deem to 

be inappropriate for publication, such as 

obscene language. All submissions that 

have been redacted or removed that 

contain comments on the merits of the 

ICR will be retained in the public 

comment file and will be considered as 

required under the Administrative 

Procedure Act and other applicable 

laws, and may be accessible under the 

Freedom of Information Act. 

FOR FURTHER INFORMATION CONTACT: 

Philip Newsom, Attorney Advisor, 

Market Participants Division, 

Commodity Futures Trading 

Commission, Three Lafayette Centre, 

1155 21st Street NW, Washington, DC 

20581; (202) 418–5301; email: 

pnewsom@cftc.gov. 

SUPPLEMENTARY INFORMATION: 

Title: Regulations Establishing and 

Governing the Duties of Swap Dealers 

and Major Swap Participants (OMB 

Control No. 3038–0084). This is a 

request for an extension of a currently 

approved information collection. 

Abstract: On April 3, 2012 the 

Commission adopted Commission 

regulations 23.600 (Risk Management 

Program), 23.601 (Monitoring of 

Position Limits), 23.602 (Diligent 

Supervision), 23.603 (Business 

Continuity and Disaster Recovery), 

23.606 (General Information: 

Availability for Disclosure and 

Inspection), and 23.607 (Antitrust 

Considerations) 2 pursuant to section 

4s(j) 3 of the Commodity Exchange Act 

(‘‘CEA’’). The above regulations adopted 

by the Commission require, among other 

things, swap dealers (‘‘SD’’) 4 and major 

swap participants (‘‘MSP’’) 5 to develop 

a risk management program (including a 

plan for business continuity and 

disaster recovery and policies and 

procedures designed to ensure 

compliance with applicable position 

limits). The Commission believes that 

the information collection obligations 

imposed by the above regulations are 

essential to ensuring that swap dealers 

and major swap participants maintain 

adequate and effective risk management 

programs and policies and procedures 

to ensure compliance with position 

limits. 

An agency may not conduct or 

sponsor, and a person is not required to 

respond to, a collection of information 

unless it displays a currently valid OMB 

control number. On January 28, 2022, 

the Commission published in the 

Federal Register notice of the proposed 

extension of this information collection 

and provided 60 days for public 

comment on the proposed extension, 87 

FR 4567 (‘‘60-Day Notice’’). The 

Commission did not receive any 

relevant comments on the 60-Day 

Notice. 

Burden Statement: The Commission 

is revising its estimate of the burden for 

this collection to reflect the current 

number of respondents and estimated 

burden hours. The respondent burden 

for this collection is estimated to be as 

follows: 

Estimated Number of Respondents: 

107. 


jspears on DSK121TN23PROD with NOTICES1
18772 Federal Register / Vol. 87, No. 62 / Thursday, March 31, 2022 / Notices 

1https://www.cpsc.gov/Business— 

Manufacturing/Testing-Certification/ 

Recommended-Procedures-Regarding-the-CPSCsPolicy-on-Animal-Testing/. 

2The Commission voted 4–0 to approve this 

notice. 

Estimated Average Burden Hours per 

Respondent: 1,148.5 hours. 

Estimated Total Annual Burden 

Hours: 122,889.5 hours. 

Frequency of Collection: As 

applicable. 

There are no capital costs or operating 

and maintenance costs associated with 

this collection. 

(Authority: 44 U.S.C. 3501 et seq.) 

Dated: March 25, 2022. 

Robert Sidman, 

Deputy Secretary of the Commission. 

[FR Doc. 2022–06751 Filed 3–30–22; 8:45 am] 

BILLING CODE 6351–01–P 

CONSUMER PRODUCT SAFETY 

COMMISSION 

[Docket No. CPSC–2021–0006] 

Notice of Availability: Final Guidance 

on Alternative Test Methods and 

Integrated Testing Approaches 

AGENCY: U.S. Consumer Product Safety 

Commission. 

ACTION: Notice of availability. 

SUMMARY: The Consumer Product Safety 

Commission (Commission or CPSC) is 

announcing the availability of a 

document titled, ‘‘Final Guidance for 

Industry and Test Method Developers: 

CPSC Staff Evaluation of Alternative 

Test Methods and Integrated Testing 

Approaches and Data Generated from 

Such Methods to Support FHSA 

Labeling Requirements.’’ 

FOR FURTHER INFORMATION CONTACT: John 

Gordon, Toxicologist, Directorate for 

Health Sciences, U.S. Consumer Product 

Safety Commission, 5 Research Place, 

Rockville, MD 20850; telephone: 301– 

987–2025; email: jgordon@cpsc.gov. 

SUPPLEMENTARY INFORMATION: The 

Federal Hazardous Substances Act 

(FHSA), 15 U.S.C. 1261–1275, requires 

that hazardous substances bear certain 

cautionary statements on their labels. 

Manufacturers may perform 

toxicological tests to determine whether 

such products require cautionary 

labeling addressing the hazard. 

Although animals are still used in 

toxicological testing, most governmental 

agencies support reduced use of animals 

in testing, by promoting the acceptance 

of data from alternative test methods. 

In 1997, the National Institute of 

Environmental Health Sciences 

(NIEHS), the National Toxicology 

Program (NTP), and 13 federal agencies 

(including CPSC) joined to form the 

Interagency Coordinating Committee for 

the Validation of Alternative Methods 

(ICCVAM). ICCVAM sponsors scientific 

review of non-animal tests (known as 

New Approach Methodologies or 

NAMs) that may reduce, refine, or 

replace animal tests in evaluating 

potential hazards. Reviews from 

ICCVAM and other federal agencies can 

provide a basis for regulatory agencies, 

such as CPSC, to consider non-animal 

testing alternatives for use in regulatory 

decision making. In the past, CPSC staff 

relied upon ICCVAM’s validation of 

new alternative testing methods, as 

reliable test methods to determine 

compliance with the labeling 

requirements of the FHSA. However, 

ICCVAM no longer validates test 

methods. 

In 2012, CPSC issued a policy on nonanimal or alternative testing methods to 

support labeling requirements under the 

FHSA, as codified under 16 CFR 

1500.232 (Animal Testing Policy). 

CPSC’s website lists current CPSCaccepted alternative test methods and 

their conditions of use.1 Since 2012, 

new advancements in toxicological 

testing, and in particular with NAMs, 

have occurred. NAMs include in vitro 

(in test tube), in chemico (all chemical 

test, no biological material), or in silico 

(computer models) methods and 

approaches used to test for toxicological 

effects in place of animal testing. In 

some cases, NAMs are combined with 

other NAMs or existing in vivo (animal) 

data to form an ‘‘integrated approach to 

testing and assessment’’ (IATAs). 

The Commission reaffirms its policy 

to find alternatives to traditional animal 

testing that replace animals, reduce the 

number of animals tested, and decrease 

the pain and suffering in animals 

associated with testing household 

products. As such, the Commission 

strongly encourages all agency 

stakeholders to submit for evaluation by 

CPSC staff any scientifically validated 

alternative test methods that do not 

require animal testing for determining 

compliance with the labeling 

requirements under the FHSA. 

Because ICCVAM no longer validates 

test methods, to assist stakeholders, 

including the public, manufacturers, 

test method developers, and test 

laboratories in determining what test 

methods are deemed reliable for 

determining compliance with the 

labeling requirements under the FHSA, 

on March 31, 2021, the Commission 

published a Notice of Availability in the 

Federal Register and requested 

comments on ‘‘Proposed Guidance for 

Industry and Test Method Developers: 

CPSC Staff Evaluation of Alternative 

Test Methods and Integrated Testing 

Approaches and Data Generated from 

Such Methods to Support FHSA 

Labeling Requirements’’ 86 FR 16704. 

CPSC received five comments that are 

addressed in the staff’s briefing package 

on the final guidance. The staff’s 

briefing package is available on CPSC’s 

website at NAM Final Guidance BVS 

(cpsc.gov). 

The CPSC has finalized its guidance 

for industry and test method 

developers.2 The final guidance informs 

the public of staff’s informational 

requirements and process for evaluating 

NAMs and IATAs. The final guidance 

does not prescribe a specific form of 

validation and explains that validation 

can be accomplished via several 

different processes. A method’s 

reliability includes reproducibility, 

repeatability, and robustness. In 

addition to the performance and 

applicability of the NAM/IATA, good 

scientific, technical, and quality 

practices will ensure that the overall 

process is more efficient and effective 

and leads to increased confidence in the 

proposed method. The final guidance 

also includes an optional NAM 

nomination form that can be used to 

organize information about a NAM or 

IATA for evaluation by CPSC staff. Such 

non-animal alternative test methods, if 

accepted by CPSC, would be considered 

reliable test methods for determining 

compliance with the labeling 

requirements under the FHSA. 

Additionally, CPSC would continue to 

list CPSC-accepted alternative test 

methods on CPSC’s website. 

The final guidance will be available 

at: https://www.regulations.gov under 

docket number, CPSC–2021–0006, 

under ‘‘Supporting and Related 

Material,’’ and on the Commission’s 

website at: https://www.cpsc.gov/ 

Business--Manufacturing/TestingCertification/RecommendedProcedures-Regarding-the-CPSCsPolicy-on-Animal-Testing. 

Alberta E. Mills, 

Secretary, Consumer Product Safety 

Commission. 

[FR Doc. 2022–06825 Filed 3–30–22; 8:45 am] 

BILLING CODE 6355–01–P 


jspears on DSK121TN23PROD with NOTICES1